Abpro Holdings Files Definitive Proxy Statement
Ticker: ABPWW · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1893219
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: ABPR
TL;DR
Abpro Holdings (ABPR) filed its DEF 14A proxy statement for the May 20th meeting. Shareholders vote on company matters.
AI Summary
Abpro Holdings, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 29, 2025, for its annual meeting on May 20, 2025. The company, formerly known as Atlantic Coastal Acquisition Corp. II until November 10, 2021, is a biotechnology firm focused on biological products. The filing details the company's governance and matters to be voted on by shareholders.
Why It Matters
This filing provides shareholders with crucial information regarding the company's annual meeting, including voting matters and executive compensation, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing for an annual meeting, not indicating new material risks.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- Abpro Holdings, Inc. (company) — Registrant
- Atlantic Coastal Acquisition Corp. II (company) — Former company name
- 20250429 (date) — Filing date
- 20250520 (date) — Meeting date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information for the annual meeting of Abpro Holdings, Inc., including details on matters to be voted upon.
When was Abpro Holdings, Inc. formerly known as?
Abpro Holdings, Inc. was formerly known as Atlantic Coastal Acquisition Corp. II until November 10, 2021.
What is the filing date of this proxy statement?
This Definitive Proxy Statement was filed on April 29, 2025.
When is the scheduled date for the shareholder meeting?
The shareholder meeting is scheduled for May 20, 2025.
What industry does Abpro Holdings, Inc. operate in?
Abpro Holdings, Inc. operates in the Biological Products sector, specifically Biological Products (No Diagnostic Substances) with SIC code [2836].
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Abpro Holdings, Inc. (ABPWW).